When: Sun., Feb. 4, 2-4 p.m. 2018
In the 1930s and 40s, Dr. Saul Hertz revolutionized medicine with his breakthrough research establishing the use of radioactive iodine (RAI), now the gold standard of targeted cancer therapy. The son of Jewish immigrants, Hertz performed his internship and residency at Cleveland’s Mount Sinai Hospital. Hertz faced many professional challenges that resulted in his contributions being falsely recorded, trivialized, or omitted from medical history. More than 80 years later, his legacy is now coming to light. Join Barbara Hertz, his daughter, for a discussion on the biases that impeded Dr. Hertz’s due recognition, and his impact on current medical practices.
Price: $12 general; $6 Maltz Museum Members